Lactate Dehydrogenase A Governs Cardiac Hypertrophic Growth in Response to Hemodynamic Stress

Chongshan Dai1, Qinfeng Li2, Herman I May1

  • 1Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Cell Reports
|September 3, 2020
PubMed

Insights

Lactate dehydrogenase A (LDHA) promotes heart cell growth under stress. Its absence causes heart failure, while lactate can rescue this defect by stabilizing NDRG3 and activating ERK signaling.

Area of Science:

  • Cardiovascular Biology
  • Metabolic Regulation
  • Molecular Cardiology

Background:

  • Cardiac hypertrophy is a response to hemodynamic stress, potentially leading to heart failure.
  • Metabolic remodeling occurs early in cardiac hypertrophy, but its precise role is unclear.
  • Lactate dehydrogenase A (LDHA) is a key glycolytic enzyme implicated in cellular metabolism.

Purpose of the Study:

  • To investigate the role of lactate dehydrogenase A (LDHA) in cardiac hypertrophic growth and heart failure.
  • To elucidate the molecular mechanisms by which LDHA influences cardiomyocyte growth under stress.

Main Methods:

  • Utilized a cardiomyocyte-restricted LDHA deletion mouse model to assess cardiac function under pressure overload.
  • Employed in vitro studies with cultured cardiomyocytes to examine LDHA's effect on cell growth.
  • Investigated the downstream signaling pathways involving lactate, NDRG3 (N-myc downregulated gene family 3), and ERK (extracellular signal-regulated kinase).

Main Results:

  • Cardiomyocyte-specific deletion of LDHA impaired cardiac hypertrophic growth and exacerbated heart failure during pressure overload.
  • LDHA knockdown in cultured cardiomyocytes inhibited pro-hypertrophic growth, whereas LDHA overexpression promoted it.
  • Lactate rescued the growth defect caused by LDHA knockdown, mediated by stabilization of NDRG3 and subsequent ERK activation.

Conclusions:

  • LDHA is essential for adaptive cardiac hypertrophic growth in response to hemodynamic stress.
  • The LDHA/NDRG3/ERK signaling axis plays a crucial role in regulating cardiomyocyte size and function.
  • Targeting the LDHA pathway may offer therapeutic potential for managing stress-induced heart conditions.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
523
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
239
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
16.2K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
182